RAPP
Rapport Therapeutics, Inc.
+0.21 (+0.52%)41.61USD116K成交股數2.0B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00 | 20.0M | – | – | 0.00 | 0.00 | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 51.4M | 32.7M | 30.3M | 22.3M | 22.7M | 19.6M | 15.5M | 15.7M | 12.5M | – | 7.6M | 4.7M |
| 銷售管理費用 | 9.4M | 11.5M | 8.3M | 7.7M | 6.8M | 7.5M | 6.1M | 5.1M | 4.6M | – | 2.0M | 1.9M |
| 營業利益 | −60.8M+106% | −24.2M-11% | −38.5M+78% | −30.0M+44% | −29.5M+73% | −27.1M | −21.6M+126% | −20.8M+214% | −17.1M | – | −9.6M | −6.6M |
| 營業利益率 | – | -121.1% | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −56.6M+112% | −19.9M-17% | −33.8M+93% | −26.9M+49% | −26.7M+18% | −24.1M+78% | −17.5M+101% | −18.1M+183% | −22.7M | −13.5M | −8.7M | −6.4M |
| 淨利率 | – | -99.3% | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -1.19+59% | -0.42-38% | -0.72+44% | -0.71-58% | -0.75-93% | -0.68 | -0.50-91% | -1.70-62% | -11.07 | – | -5.70 | -4.45 |
| 稀釋股數 | 47.5M | 47.2M | 38.9M | 37.9M | 35.4M | 35.3M | 34.9M | 10.7M | 2.0M | 1.5M | 1.5M | 1.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 63.6M | 78.1M | 52.6M | 251M | 55.1M | 57.6M | 39.3M | 110M | 74.3M | 70.2M | 159M | 79.5M |
| 應收帳款 | 293K | 58K | 0.00 | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 459M | 498M | 512M | 535M | 285M | 302M | 331M | 346M | – | 155M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 36.1M | 26.1M | 27.8M | 23.7M | 22.0M | 16.2M | 8.0M | 9.2M | – | 14.5M | – | – |
| 股東權益 | 423M | 472M | 485M | 512M | 264M | 286M | 323M | 337M | −39.6M | −25.6M | −13.1M | −9.4M |
| 負債比 | 7.9% | 5.2% | 5.4% | 4.4% | 7.7% | 5.4% | 2.4% | 2.7% | – | 9.3% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −13.1M-35% | – | – | – | −20.2M | – | – | −17.6M | – | – | – |
| 資本支出 | – | 86K | – | – | – | 291K | – | – | 1.1M | – | – | – |
| 自由現金流 | – | −13.1M-36% | – | – | – | −20.5M | – | – | −18.7M | – | – | – |
| 折舊攤銷 | – | 227K | – | – | – | 244K | – | – | 152K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -65.7% | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −111M | –% | -2.86 | −88.1M |
| FY2024 | – | – | −78.3M | –% | -3.78 | −67.2M |
| FY2023 | – | – | −34.8M | –% | -23.10 | −28.8M |